Harbour Biomed Launches ‘ideas To Ind Subsidiary Health Tech World
Harbour Biomed Launches ‘ideas To Ind Subsidiary Health Tech World
Harbour Biomed Launches ‘ideas To Ind Subsidiary Health Tech World
785×600
Harbour Biomed Launches Nona Biosciences Ideas To Ind Preclinical
Harbour Biomed Launches Nona Biosciences Ideas To Ind Preclinical
890×700
Harbour Biomed Announces Multi Year Transgenic Platform Licensing
Harbour Biomed Announces Multi Year Transgenic Platform Licensing
1200×627
Harbour Biomed Announces Ind Clearance For First In Class Anti B7h7
Harbour Biomed Announces Ind Clearance For First In Class Anti B7h7
1048×460
China Based Startup Harbour Biomed Enters Into Collaboration With Moderna
China Based Startup Harbour Biomed Enters Into Collaboration With Moderna
1000×600
Harbour Biomed Announces The Latest Clinical Data On The First In Class
Harbour Biomed Announces The Latest Clinical Data On The First In Class
777×446
Harbour Biomed Starts Hbm4003 Dosing In Phase I Solid Tumours Trial
Harbour Biomed Starts Hbm4003 Dosing In Phase I Solid Tumours Trial
800×660
Harbour Biomed Teams Up With Wistar To Discover Novel Mabs Nai 500
Harbour Biomed Teams Up With Wistar To Discover Novel Mabs Nai 500
600×375
Harbour Biomed Cttq Unite To Discover Develop And Commercialize
Harbour Biomed Cttq Unite To Discover Develop And Commercialize
1280×720
Wuxi Biologics Reveals First Hcab Partnership Alongside Harbour Biomed
Wuxi Biologics Reveals First Hcab Partnership Alongside Harbour Biomed
750×482
Harbour Biomed And Rotterdam Strengthen Ties During Shanghai Rotterdam
Harbour Biomed And Rotterdam Strengthen Ties During Shanghai Rotterdam
980×450
Biomed X Launches A New Call For Application In Autoimmune Disease Research
Biomed X Launches A New Call For Application In Autoimmune Disease Research
1417×487
Harbour Biomed Reports The Latest Progress From Phase I Clinical Trial
Harbour Biomed Reports The Latest Progress From Phase I Clinical Trial
1280×720
Harbour Biomed Presented Pre Clinical Data On A Fully Human Anti Cd73
Harbour Biomed Presented Pre Clinical Data On A Fully Human Anti Cd73
763×509
Biomed X Launches Xseed Labs In The Us With Boehringer Ingelheim A
Biomed X Launches Xseed Labs In The Us With Boehringer Ingelheim A
600×350
Harbour Biomed And City Of Rotterdam Strengthen Ties
Harbour Biomed And City Of Rotterdam Strengthen Ties
980×553
Harbour Biomed Presents Novel Antibody For Cancer Immunotherapy At 2021
Harbour Biomed Presents Novel Antibody For Cancer Immunotherapy At 2021
599×333
Health Tech World Presents Ageing And Innovation A Global Debate
Health Tech World Presents Ageing And Innovation A Global Debate
1536×864
Harbour Biomed Announces Last Patient Dosing Of Phase1b2a Study Of
Harbour Biomed Announces Last Patient Dosing Of Phase1b2a Study Of
1920×1080
Harbour Biomed Aims To Develop Cancer Therapy Nextbigproduct
Harbour Biomed Aims To Develop Cancer Therapy Nextbigproduct
1024×489
The Us Has Granted Ind Approval To Hbm9033 The Initial Adc Project
The Us Has Granted Ind Approval To Hbm9033 The Initial Adc Project
2000×658
Humanetics Medical Device Subsidiary Gets New Sales Deal Techcentury
Humanetics Medical Device Subsidiary Gets New Sales Deal Techcentury
1849×874
Health Tech Forward 2022 The Gallery Health Tech World
Health Tech Forward 2022 The Gallery Health Tech World
1000×667
Harbour Biomed Inks Agreement For ‘next Generation Biologic Discovery
Harbour Biomed Inks Agreement For ‘next Generation Biologic Discovery
750×500